Is NOZAX a Scam?

At FXCanary, our safety analysis is built on a multidimensional framework that goes far beyond a simple binary verdict of ‘scam or safe’. We cross-check regulatory registrations against official public registers, scrutinise the quality and enforceability of client-fund protections, weigh aggregated user feedback for patterns of withdrawal obstruction, and examine corporate structure for transparency red flags.

NOZAX, operating under the legal entity NOZAX AD, presents a mixed picture. It holds a single derivatives trading licence from the Capital Market Authority of Montenegro (SCMN), a regulator that exists but lacks the robust compensation schemes and supervisory teeth of top-tier bodies like the FCA or ASIC. Our composite Scam Risk Score for NOZAX is 36 out of 100, which places it in the ‘Guarded’ category – not an outright alarm, but a clear signal that traders should proceed with their eyes wide open.

That score reflects the tension between the broker’s largely positive user sentiment and the structural vulnerabilities inherent in its regulatory setup. In the following sections, we unpick exactly what that means for anyone considering depositing funds with this broker.

NOZAX is authorised by the Capital Market Authority of Montenegro (SCMN) under derivatives trading licence number 03/2-5/5-21. While the SCMN is a genuine financial regulator and Montenegro is not an unregulated offshore haven, it is also not a jurisdiction known for aggressive enforcement or meaningful investor compensation. The licence permits NOZAX to operate as an STP broker, but the actual protections afforded to retail clients are thin.

Unlike brokers regulated in the UK or EU, NOZAX’s clients do not benefit from a statutory investor compensation scheme that would cover losses in the event of the firm’s insolvency. There is no explicit negative-balance protection mandated by Montenegrin law, meaning traders could technically owe more than their deposit, though in practice retail brokers often limit this risk contractually. Segregation of client funds is required, but without a strong external oversight or regular third-party audits, the assurance is less robust than under FCA or CySEC rules.

Furthermore, NOZAX’s corporate registration shows zero employees, which is an unusual flag for an active brokerage. While it could mean the firm relies heavily on outsourced services and technology, it also suggests a very lean operation that may struggle to provide robust support or dispute resolution when things go wrong.

FXCanary’s Scam Risk Score aggregates several weighted factors: regulatory strength, years in operation, transparency of fees and corporate structure, user reports of withdrawal problems, and the presence of clone or impersonation scams. NOZAX’s 36/100 breaks down as follows: the SCMN licence provides a baseline of legitimacy but earns only a moderate score for weak enforcement and no compensation fund; the broker was founded in August 2022, giving it a very short track record; and although user reviews are mostly positive, the number of withdrawal-related complaints – 14 in our industry databases – weighs heavily.

Notably, we found no evidence of clone or impersonator websites posing as NOZAX, which is a positive sign that the brand is not yet a target for that particular type of fraud. However, the absence of a longer operating history means that the broker has not yet been tested through a full market cycle or period of extreme volatility, when weak points in liquidity or risk management often surface.

The ‘Guarded’ rating is our way of saying that while there is no smoking gun, the cumulative risks are real. Traders should treat this score as a prompt to dig deeper into the broker’s actual practices – especially around withdrawals – before committing larger sums.

User sentiment on platforms like Trustpilot paints a largely upbeat picture: a 4.4-star average from 69 reviews suggests most clients are satisfied. Common praise centres on low spreads, fast execution, and helpful customer support. Terms like ‘trusted broker’ and ‘transparent system’ appear repeatedly. However, the positive noise can mask deeper issues.

Our analysis surfaced 14 specific complaints related to deposit or withdrawal failures. The raw numbers may seem small, but they follow a worrying pattern: clients report that withdrawals are rejected without explanation, and in some cases funds are not returned to the trading wallet. One review states bluntly, ‘My deposit was rejected but the funds are held… no response at all.’ Another asks, ‘Why did my withdrawal funds fail, and why didn’t they return to my wallet account again?’ These are not isolated grumbles; they hint at operational friction or, at worst, a reluctance to release funds.

It’s important to note that many other users report smooth and fast withdrawals, and the broker’s localised payment options – including Indonesian bank transfers and support for IDR Cent accounts – have clearly resonated in certain markets. Still, a broker that cannot consistently and transparently process withdrawals raises a fundamental trust question: is your money safe when you want it back?

Even without the headline-grabbing signs of an outright scam, NOZAX presents several red flags that collectively demand caution. First, the disparity between its claimed founding year (2017) and its actual registration date (August 2022) is concerning. A five-year gap in provenance is not easily explained by a simple corporate restructuring, and potential clients deserve a clear account of the broker’s history.

Second, the zero-employee filing is a transparency red flag. A regulated brokerage that claims to serve retail clients should have a verifiable physical presence and staff to handle compliance, support, and operations. While virtual offices and outsourced functions are common, a registered headcount of zero undercuts the image of a substantive financial institution.

Third, the repeated withdrawal complaints, while not the majority, expose a common thread of poor communication and possible delays. When a broker fails to explain why a withdrawal fails and simultaneously holds onto the client’s deposit, it erodes the very trust that its positive reviews try to build.

It would be unfair to paint NOZAX as wholly negative. The broker offers a legitimate STP licence, which means client orders should be passed directly to liquidity providers without a dealing-desk conflict of interest. Its account types – CENT, CORE, and ZERO – cater to different trader profiles, and the availability of a Cent Account in IDR is a genuine plus for Indonesian traders who want to avoid complex currency conversions.

User feedback consistently highlights low spreads, fast execution, and a user-friendly MT5 platform. Many clients mention responsive customer support in local languages, and some describe the educational resources and profit opportunities positively. The broker’s acceptance of multiple deposit and withdrawal methods, including local bank transfers and Skrill, adds convenience.

Crucially, we found no clone or impersonator sites targeting NOZAX. This suggests the broker’s online presence is not yet being exploited by fraudsters, which reduces the risk of accidentally dealing with a fake entity. For a young broker, maintaining a clean, uncontaminated digital footprint is a non-trivial achievement.

If you choose to trade with NOZAX, the ‘Guarded’ score means you should take proactive steps to safeguard your funds. Start small: deposit only what you can afford to lose until you’ve personally tested the withdrawal process. Document everything – screenshots of deposits, trade confirmations, and support chats – because in a dispute, a clear paper trail is your best defence.

Test withdrawals early and often. Do not wait until you have a large balance to request a payout. A small withdrawal that is processed smoothly is reassuring; a failed one is an immediate signal to exit. If you encounter resistance, escalate formally via email and keep copies of all correspondence. Should the broker become unresponsive, you may need to contact the SCMN, though its ability to help is limited compared to major regulators.

Diversify your broker relationships. Putting all your trading capital with one firm, especially one with a short track record and a moderate risk score, is unnecessary. Use payment methods that offer their own dispute resolution (like credit cards or Skrill) where possible, as they may provide a chargeback option if things go wrong. Above all, maintain a healthy scepticism: glowing reviews are easy to generate, but genuine safety is proven over time and under stress.

NOZAX is not a confirmed scam, but neither is it a bench-mark safe harbour for retail funds. Its Montenegrin licence offers a fig leaf of legitimacy, but the lack of a compensation scheme, zero reported employees, and a cluster of unresolved withdrawal complaints keep our risk assessment firmly in the ‘Guarded’ territory.

For experienced traders who understand the trade-offs and are comfortable with the risks, NOZAX’s low-cost structure and local-market tailoring may be attractive. For newcomers or those prioritising capital safety above all else, there are far more robustly regulated alternatives. As always at FXCanary, our role is to illuminate the facts – and the facts here demand caution.